April 10, 2017
GreyBird Ventures invests in and helps to build companies that solve critical diagnostic problems in precision medicine. Our unique and singular focus allows us to partner with entrepreneurs that meet our stringent criteria from the hundreds of new technologies coming to us from around the world.
Beginning with our first investment in early 2016, each GreyBird company has the potential to dramatically change the standard of care and improve patient health.